Apyx Medical CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Apyx Medical Corporation has issued its 2026 proxy statement, seeking shareholder approval for a new share incentive plan and the re-election of its board of directors.
NASDAQ
DEF: Apyx Medical Prepares for 2025 Annual Meeting Amidst Financial Headwinds and Strategic Restructuring
Apyx Medical Corporation announces its 2025 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, executive compensation, and a critical amendment to its Certificate of Incorporation tied to a credit agreement, following a year of decreased revenue and increased operating losses.
NASDAQ
Apyx Medical Corporation will hold its 2024 Annual Meeting of Stockholders on August 8, 2024, to elect directors and ratify the company's independent auditor.